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Abstract: Background: hepatocellular carcinoma (HCC) is the third cause of mortality due to 
cancer throughout the world.  
Objective: The main goal of the current research was to evaluate the selective toxicity of 
apigenin (APG) on hepatocytes and mitochondria obtained from the liver of HCC rats).  
Method: In this research, HCC induced by a single dose of diethylnitrosamine (DEN); 200 
mg/kg, i.p, and 2-acetylaminofluorene (2-AAF) (0.02%, through dietary) for 14 days. For 
confirmation of HCC, histopathological evaluations and determination of serum concentrations 
of liver toxicity enzymes and specific liver cancer marker; alpha-fetoprotein (AFP) were 
performed. Then, cancerous and non- cancerous hepatocytes were isolated by using the collagen 
perfusion method. Eventually, mitochondria isolated from HCC and normal hepatocytes were 
tested for every eventual toxic effects of APG.  
Results: After confirmation of HCC, the results of this research showed that APG (10, 20 and 40 µM) increased 
mitochondrial parameters such as, mitochondrial membrane potential (MMP), reactive oxygen species (ROS) level, 
mitochondrial swelling and cytochrome c expulsion only in cancerous hepatocytes. Apoptotic effect of APG on HCC 
cells was confirmed by caspase-3 activation and Annexin V-FITC and PI double staining analysis.  
Conclusion: These results propose the eligibility of the flavonoid APG as a complementary therapeutic agent for 
patients with hepatocellular carcinoma. 
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INTRODUCTION 
 Among the most common malignancies hepatocellular 
carcinoma (HCC) possesses the fifth place and one of the deadliest 
cancers throughout the world [1]. The main risk factors for this 
cancer include the hepatitis viral infection (HBV and HCV), food 
additives, alcohol, aflatoxin B1, toxic industrial chemicals, air and 
water pollutants [2]. The metabolism of ingestion materials is 
performed in the human liver and therefore is vulnerable to 
carcinogenic assault. On the other side, the liver tolerance is high.In 
particular, in patients for whom cancer could not be detected in 
early stage [3]. 
 Despite being a potentially medicinal type of therapy used in 
the treatment of HCC including chemotherapy, liver resection and 
transplantation, these treatment methods have a poor tolerance and 
low efficacy and poor subsequent survival rate, respectively. So, the 
determination of best choice therapy with good potency and 
efficacy is urgently needed [4].  
 Plant flavonoids are a known family of plant metabolic 
compounds [5]. Epidemiologic researches show an anti-cancer 
effect of high dietary intake of flavonoids and other natural food  
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product [6]. It is assumed that natural food compound contain 
products that have protective effects against diseases (including 
various cancers). These effects also independent of those known 
nutrients and micronutrients [7]. Various flavonoid compounds due 
to differences in chemical structure, and pharmacokinetic parameters 
such as absorption, distribution have a different effect on human 
health [5, 7]. Apigenin (APG), a flavone, is found in natural product 
food such as fruits [8]. It has been shown that APG has a different 
functions and biological properties, including anti-inflammatory, 
anti-cancer, and anti-oxidant properties [9]. 
 The results of in vitro studies on different cancer cell lines 
showed that APG has inhibited the growth of cancer cell via 
inducing cell cycle arrest and apoptosis [10]. Moreover, APG is 
reportedly non-mutagenic, low and ignorable of toxicity compared 
with other flavonoids [11]. Thus, APG may be a good candidate 
compound for anticancer drugs [12]. In the several studies, animal 
models are commonly used to assess the anti-cancer effects of 
natural compounds, particularly the polyphenols [13]. The compounds 
such as diethylnitrosamine (DEN) and 2- acetylaminofluorene (2-AAF) 
are commonly used in cancer research to create models of cancer, 
especially liver cancer [14].  
 In our study, we aimed to determine the selective apoptotic 
effects of APG on hepatocytes and mitochondria obtained from the 
liver of HCC rats in comparison with those of untreated normal 
rats. So far there is no report regarding the anti-cancer or apoptotic 
effects APG has on HCC liver hepatocytes.  
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MATERIALS AND METHODS 
Animals 
 Male Sprague-Dawley rats (120–130 g), fed a standard chow 
diet and given water ad libitum, were used in all experiments. Rats 
were purchased from Institute Pasteur (Tehran, Iran). All rats were 
kept in a controlled room temperature of 20∘C–25∘C and humidity 
50%–60% and were faced to 12 h light/dark cycles. The animal 
treatment in this study was according to the ethical guidelines 
issued by the Committee of Animal Experimentation of Shahid 
Beheshti University of Medical Sciences, Tehran, Iran.  
Experimental Method 
 Briefly, the rats were divided into two groups and 5 rats were 
placed in every group. Group A was an untreated normal group 
(Fig. 1). In this research, HCC was induced by DEN; as a single 
dose 200 mg/kg, i.p, and 2-AAF (0.02%, through dietary) for 14 
days (group B) [14]. The body weight was recorded every week for 
15 weeks. Afterward, the blood samples were permitted to 
coagulate and centrifugation for 10 min at 1000×g and 4 ◦C to 
access serum for evaluation of Alpha-Fetoprotein (AFP), alanine 
transaminase (ALT), Aspartate transaminase) AST), and Alkaline 
phosphatase (ALP). At the end of the estimated HCC induction 
process (week 15), 5 rats were sacrificed with an overdose of 
barbiturate. The tissue samples from liver both groups were 
harvested and were kept for histological evaluation. If HCC 
confirmed by the histological analysis, mitochondria were then 
isolated from liver hepatocytes of the remaining animals (A and B 
groups). 
Alpha-Fetoprotein (AFP) Assay 
 AFP concentration levels on animal’s serum were assayed using 
the method of Taha et al., [14]. 
Biochemical Assessments 
 The activities of ALT, AST and ALP on animal’s serum were 
evaluated using the method of Taha et al., [14]. 
Histopathological Analysis 
 Histopathological examination was assayed by using the 
method of Taha et al., [14]. 
ISOLATION OF MITOCHONDRIA FROM RAT 
HEPATOCYTES 
 In our study, the isolation of rat hepatocytes from liver both 
groups were isolated using the two-step collagenase liver perfusion 
technique [15]. Then, to determine the cell membrane lysis the 
trypan blue uptake was used. After isolation of hepatocytes from 
both groups, cancerous and non-cancerous hepatocytes were 
categorized using flow cytometry. In the next step, mitochondria 
from both groups are prepared from hepatocytes (30 ×106 cells) 
[15b]. The hepatocytes are afterwards pelleted (300 g for 3min) and 
re-suspended in 10 ml of Solution A (0.01M tricine, 0.25M sucrose, 
10mM NaH2PO4, 1mM EDTA, 2mM MgCl2 at pH= 8). Finally, the 
differential centrifugation (5min at 760× g for the first stage and 20 
min at 8000 × g for the second stage) were used in isolation of 
mitochondria from hepatocytes [16]. For the determination of ROS 
generation, mitochondrial swelling and MMP, the mitochondria 
were suspended in corresponding buffer, respectively. The 
concentrations of APG (10, 20 and 40 µM) were selected based 
MTT assay (1/2 IC50, IC50 and 2 IC50). 
SUCCINATE DEHYDROGENASE (SDH) ACTIVITY ASSAY  
 In this study, the alteration of SDH or mitochondrial complex II 
activity by APG (0-100µM was measured by reduction of MTT [17]. 
DETERMINATION OF ROS LEVEL 
 Isolated mitochondria from control and HCC hepatocytes were 
placed in respiration buffer. Following this step, DCFH 
(Fluorescent probe) was utilized for the mitochondrial ROS level at 
the EXλ= 488 nm and EMλ=527 nm [15b]. 
MEASUREMENT OF CHANGES IN MMP  
 Isolated mitochondria from normal and HCC hepatocytes were 
placed in MMP buffer. In the next step, Rhodamine 123 (Rh 123, a 
cationic fluorescent dye) MMP used for the MMP assay at the 
EXλ= 490 nm and EMλ=535 nm [15b]. 
MITOCHONDRIAL SWELLING ASSAY 
 In this experiment, isolated mitochondria from normal and 
HCC hepatocytes were suspended in swelling buffer and incubated 
with 10, 20 and 40 "M of APG. Finally, absorbance was assayed at 
540 nm [15b]. 
 
Fig. (1). Experimental method of this study. The animal were separated into two experimental groups; A (normal group), B (HCC group). Group A rats served 
as control animals and was fed a standard diet until end of the experimental duration (15 week). HCC induced by diethylnitrosamine (DEN); at a single dose 
200 mg/kg, i.p, and 2-acetylaminofluorene (2-AAF) (0.02%, through dietary) for 14 days and then were on the standard diet until end of experimental time 
(15week). 
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CYTOCHROME C (CYT C) TEST 
 The release of cytochrome c by APG was assayed by the 
Quantikine Rat/Mouse Cytochrome c Immunoassay kit provided by 
R & D Systems, Inc. (Minneapolis, Minn.). 
HEPATOCYTES VIABILITY 
 Cytotoxicity was determined by MTT test. Hepatocytes from 
normal and HCC cells were exposed to 2.5-100 µM concentration 
of APG (made up with the RPMI 1640) for 48h. In the end, 
absorbance to the each group was determined at 570 nm in a 
microplate reader [18]. 
ROS ASSAY BY FLOW CYTOMETRY 
 In this study, ROS level was observed by flow cytometry using 
DCHF-DA[19]. Hepatocyte from normal and HCC groups were 
treated with APG (10 µM). Following this step, ROS production in 
6, 12 and 24 h, respectively, were measured [20]. 
MMP ASSAY VIA FLOW CYTOMETRY 
 After treatment with a concentration of APG (10 µM) for 24h, 
the hepatocytes cells obtained from normal and the HCC group 
were incubated with Rh123 (1 mg/ml in DMSO) for 30 min at 37 ℃ and washed 3 times with PBS. The hepatocytes groups were both 
examined by flow cytometry technique at the EXλ= 488 nm and 
EMλ=530 nm. 
DETERMINATION OF CASPASE-3  
 The caspase-3 activity in both groups were assayed by using the 
Sigma’s caspase-3 assay kit (Sigma- Aldrich, Taufkirchen, Germany) 
[21]. The concentration of the p-nitroaniline released from the 
substrate at 405 nm used for assay caspase 3 activity [22]. 
QUANTIFICATION OF APOPTOSIS 
 For evaluation of apoptosis by flow cytometry, the Annexin V-
FITC detection kit was used. The cells were placed at 6-well plates 
and treated with APG (10 µM) for 6, 12 and 24 h. The % of alive, 
dead, and apoptotic cells were assayed [18]. 
STATISTICAL ANALYSIS 
 The all results in this study are shown as mean ±SD. The 
statistical analyses were carried out by the Graph Pad Prism 
software (version 5) using one-way and two-way ANOVA followed 
by Tukey and Bonferroni post hoc tests, respectively. All 
measurements were performed triplicate. Statistical significance 
was set at $< 0.05.  
RESULTS 
Alteration of Body and Liver Weights by the DEN/2-AAF 
Regime 
 In our study, Table 1A shows the body (final) and liver weights 
of control (A) and HCC group (B) of rats. The average body weight 
of normal group (A) of rats (282.33 ± 13.65 g) was significantly (P 
< 0.05) higher than the HCC group (B) rats (215.33 ± 4.72 g). 
Moreover, in the HCC group the average liver weight of rats (13.58 
± 0.62 g) after 15 weeks were significantly (P < 0.05) higher than of 
normal group (9.66 ± 1.04 g).  
Effect of DEN/2-AAF Regime on Serum AST, ALT and ALP 
and Specific HCC Marker 
 Rats treated with DEN/2-AAF to induce hepatocellular 
carcinoma showed significant (P < 0.05) increase in serum AST, 
ALT and ALP as well as serum AFP concentrations (Table 1B). 
Histopathology 
 The histopathological findings on hepatic slices from two 
groups (A and B) are shown in Fig. (2A-C). In the hepatic slices 
from normal group rats, there was normal liver parenchyma with 
the typical architecture characterized by central vein, granulated 
cytoplasm, and small uniform nuclei (Fig. 2A). Hepatic sections of 
the HCC group exhibited atypical architecture with hyperchromatic 
nuclei and a significant variation in nuclear size were also 
binucleated (Fig. 2B and C). 
Cytotoxicity Effect of APG on Hepatocyte 
 The cytotoxicity effect of APG on hepatocytes isolated from 
untreated control and HCC groups were determinate after incubation 
in culture medium including APG at concentrations of 2.5, 5. 10, 25, 
50 and 100 µM for 48 h. As shown in Fig. (2E), APG significantly 
reduced cell viability in hepatocytes obtained from HCC rats in a 
concentration -dependent manner; But only little decrease was remarked 
on cytotoxicity effect at normal group hepatocytes following the 
addition of the highest dose of APG (100 µM) (Fig. 2D). 
Effect of APG on SDH Activity 
The effect of APG (0, 5, 10, 20, 50 and 100µM) on mitochondrial 
SDH activity was measured by the MTT test, using mitochondria 
isolated from liver hepatocytes of both A and B groups following 
Table 1. (A) Effect of DEN/2-AAF regime on final body and liver weights. All results were reported as the mean ± SD. Five rats were placed in 
each group. (B) Effects of HCC inducing DEN/AAF regimen on the liver injury enzyme and AFP in serum of the test and control 
animals. All results were reported as the mean ± SD. Five rats were placed in each group. 
A 
Liver Weight (g) Final Body Weight (g) Group 
9.66± 1.04 282.33± 13.65 Untreated control group (A) 
13.58± 0.62* 215.33± 4.72* HCC group (B) 
 
B 
AFP (IU/L) ALP (IU/L) AST (IU/L) ALT (IU/L) Group 
0.46±0.05 628±10 86±17 97±15 Untreated control group (A) 
2.86± 0.32* 772± 38* 680± 67* 789± 54* HCC group (B) 
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60 min of incubation. Our results showed a significant concentration-
dependent decrease in the SDH activity (P<0.05) (Fig. 2G) only in 
the HCC rats group. But in the normal rats group only the highest 
concentration of APG (100µM) could induce significant decrease in 
the mitochondrial enzyme activity (P<0.05) (Fig. 2F).  
 
Fig. (2). Histopathological analysis. (A) Liver section from the normal group shows normal cellular architecture (H&E; 40×magnification). (B and C) Liver 
sections from the HCC group show areas of aberrant hepatocellular phenotype with variation in nuclear size, hyperchromatism, binucleation, and irregular 
sinusoids (H&E; 40×magnification). (D-E) Effect of APG (2.5–100 µM, for 48 h) on hepatocytes viability. All results were reported as the mean ± SD (n = 3). 
*P < 0.05, **P < 0.01 and ***P < 0.001: significantly different from the vehicle only group (APG concentration=“0”). (F-G) The effect of APG concentrations 
on the SDH activity in the liver mitochondria obtained from hepatocytes of normal (F) and HCC groups (G). All results were reported as the mean ± SD (n = 
3). ***P < 0.001 compared with control mitochondria (APG concentration=“0”). (H) Effect of APG on mitochondrial ROS level. The results showed that 
different concentrations of APG (10, 20 and 40 µM) were increased ROS level in the mitochondria HCC group (at various time intervals within 1h of 
incubation). Values presented as mean ± SD (% = 3). *, *** Significant difference in comparison with corresponding untreated HCC group (p<0.05, p<0.001, 
respectively). (I) Evaluation of the decline of MMP. The results showed that different concentrations of APG (10, 20 and 40 µM) were induced the collapse of 
MMP in the mitochondria HCC group (at various time intervals within 1h of incubation). Values presented as mean ± SD (% = 3).**, *** Significant difference 
in comparison with corresponding untreated HCC group (p<0.01, p<0.001, respectively). 
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Effect of APG on Mitochondrial ROS Level 
 As displayed in Fig. (2H), various concentrations of APG (10, 20 
and 40 µM) induced significant H2O2 formation ($< 0.05) in the 
mitochondria from HCC group. Lower concentration of APG 
(10µM) significantly raised H2O2 the generation only at 45 and 
60min time points, whereas the (20 µM) concentration significantly 
increased H2O2 formation at the earlier time of 30min as well as at 
45 and 60 min. However the highest concentration of APG (40µM) 
significantly increased H2O2 formation at all-time points of 5, 15, 
30, 45 and 60 min compared with their corresponding unexposed 
HCC mitochondria. Also, various concentrations of APG (10, 20 
and 40 µM) did not induce significant H2O2 formation within 
60min of incubation in the mitochondria from normal group. 
Effect of APG on MMP 
 It was shown that APG concentrations (10, 20 and 40 µM) 
significantly (p<0.05) decreased the MMP in the mitochondria 
from HCC group compared with those of their corresponding 
unexposed HCC group. On the other hand, APG at the above 
mentioned concentrations (10, 20 and 40 µM) did not induce 
significant (p<0.05) MMP within incubation time (60 min) in the 
mitochondria from normal rats group compared with those of their 
corresponding untreated normal group (Fig. 2I).  
ALTERATIONS IN MITOCHONDRIAL SWELLING BY 
APG 
 The results in Fig. (3A), various concentrations of APG (10, 20 
and 40 µM) significantly increased the mitochondrial swelling 
within the incubation time (1 hour) only in the mitochondria of 
HCC group. Addition of same concentrations of APG did not induce 
mitochondrial swelling in the mitochondria from normal group.  
 The decrease in absorbance at 540 nm is indicative of 
mitochondrial swelling. 
ALTERATIONS IN CYTOCHROME C (CYT C) 
EXPULSION BY APG 
 As shown in Fig. (3B), APG (20 "M) caused the significant 
expulsion of cyt c only in the mitochondria from HCC group.  
Pretreatment of APG (20 µM)-treated mitochondria from the HCC 
group accompanied by cyclosporine A (CsA), as a MPT inhibitors 
like, and butylated hydroxyl toluene (BHT), as a antioxidants, 
 
Fig. (3). (A) The effect of APG (10, 20 and 40 µM) on mitochondrial swelling. The mitochondrial swelling in both groups were measured within 1 h of 
incubation. All results were reported as the mean ± SD (n = 3). *** Significant difference in comparison with corresponding untreated HCC group (p<0.001). 
$significant difference in comparison with untreated HCC plus APG (20µM) (p<0.001). (B) Cytochrome c expulsion assay by using corresponding rat/mouse 
cytochrome c ELISA kit. Increased cytochrome c expulsion after addition of a concentration of APG (20 µM) in the mitochondria obtained from hepatocytes 
of HCC group but not normal groups. Also, Pretreatment of APG (20 µM)-treated mitochondria from HCC group accompanied by CsA and BHT inhibited cyt 
c expulsion as compared with APG -treated HCC group. Values presented as mean ± SD (% = 3). ***Significant difference in comparison with untreated normal 
and untreated HCC groups (p<0.001). # Significant difference in comparison with HCC plus APG (20 µM) (p<0.05). (C) Evaluation of caspase 3 activity by 
using Sigma-Aldrich kit. Caspase-3 activation in the both HCC and untreated control rat hepatocytes following the exposure to APG (10 µM). HCC and 
control rat hepatocytes were incubated in RPMI 1640 medium. All results were reported as the mean ± SD (n = 3). *** Significant difference in comparison 
with corresponding untreated HCC group (p < 0.001). (D-G) MMP assay by flowcytometry. APG significantly decline the MMP (ΔΨm) in the hepatocytes 
obtained from HCC group. The double peak for the Rh123 fluorescence indicates redistribution of part of the dye into cytosol. D) Untreated normal group 
(24h); E) Untreated HCC group (24h); F) Untreated normal plus APG (10 µM) (24h); G) Untreated HCC plus APG (10µM) (24h). 
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inhibited cyt c expulsion as compared with APG -treated HCC 
group. These results confirm the direct action of oxidative stress 
process and MPT pore opening in cyt c expulsion. 
Effect of APG Treatment on Caspase-3 Activation 
 In this study, caspase-3 activity was significantly raised in 
hepatocytes isolated from only HCC rats group when incubated 
with APG (10 µM), but not in those of obtained from the normal 
rats group (Fig. 3C). 
APG Causes Dissipation of MMP in HCC Hepatocytes 
 Rhodamine 123 cathionic fluorescent probe was used to 
evaluate the changes in the MMP (ΔΨm), which accumulates in the 
mitochondrial inter-membrane apace and redistributes into the 
cytosol following the dissipation of mitochondrial membrane 
potential and membrane depolarization. The double fluorescence 
peak observed was indicative of redistribution of rhodamine 123 
into the cytosol and collapse of the ΔΨm and depolarization of the 
mitochondrial membrane. As shown in Fig. (3G), the significant 
collapse of the ΔΨm was observed only in the hepatocytes isolated 
from HCC rats group (B) 24 h after exposure with APG (10 µM). 
Effect of In Vitro APG on Hepatocytes ROS Level 
 In our study, concentration of APG (10µM) caused significant 
ROS (H2O2) formation in hepatocytes isolated from HCC 
hepatocytes in vitro using flow cytometry assay (Fig. 4). APG -
induced elevation in H2O2 production in hepatocytes isolated from 
 
Fig. (4). ROS measuremeant by flowcytometry. ROS level after the addition of APG (10 µM) at of 6, 12 and 24h time points. A) Untreated normal (24h); B) 
HCC normal (24h); C) Untreated normal plus APG (10µM) (6h); D) Untreated normal plus APG (10 µM) (12h); E) Untreated normal plus APG (10 µM) 
(24h); F) Untreated HCC plus APG (10 µM) (6h); G) Untreated HCC plus APG (10µM) (12h); H) Untreated HCC plus APG (10 µM) (24h); I). F-H show 
increased DCF fluorescence intensity (H2O2 production) as the DCF peak shifts right ward on the x-axis. FL1: the fluorescence intensity of DCF. ***P˂0.001; 
compared with untreated normal and untreated HCC and untreated normal plus APG (10 µM). 
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HCC group was compared with the control normal and control 
HCC groups. Fig. (4F-H) shows APG (10µM) induced increased 
DCF fluorescence intensity (H2O2 production) as the DCF peak 
shifted rightward on the x-axis. 
Effect of the APG on Cell Apoptosis 
 The % apoptosis / necrosis caused by APG were quantified 
using Annexin V-FITC and PI with flow cytometry. Annexin V 
staining can detect phosphatidylserine and as such could be used for 
its analysis. The corresponding dot-plots illustrate apoptosis status, 
which are displayed in Fig. (5). The percentage of apoptotic cells 
(both early and late apoptosis) treated with APG (10 µM) at 12 and 
24 hour time points were 25.43% ± 2.4% and 1.54%± 0.9% (12h), 
19.19% ± 2% and 32.5%± 3% (24h), respectively (Fig. D-F). 
DISCUSSION  
 Today, a variety of cancers as a global health problem have 
been reported, which are also the second cause of death after 
 
Fig. (5). Induction of apoptosis by APG (10µM) in the hepatocytes isolated from normal and HCC groups. Hepatocytes were incubated with APG (10 µM) for 
0, 12 and 24 hours. A) Untreated normal (24h); B) Untreated HCC (24h); C) Untreated normal plus APG (10µM) (24h); D) Untreated HCC plus APG (10µM) 
(6h); E) Untreated HCC plus APG (10µM) (12h); F) Untreated HCC plus APG (10µM) (24h);G) Four different cell populations were detected after the 
Annexin V/PI staining of hepatocytes (Q1; the necrotic dead cells, Q2; the ruptured apoptotic bodies representing the late apoptosis, Q3; the viable cells, Q4; 
the apoptotic cells representing the early apoptosis). 
8    Anti-Cancer Agents in Medicinal Chemistry, 2016, Vol. 16, No. 0 Seydi et al. 
cardiovascular disease [23]. The results of the studies show that the 
incidence of HCC is rising and the disease remained as one of the 
important subjects for liver transplantation. Two common types of 
hepatitis, including HBV and HCV are the main risk factors for 
HCC [24]. Experimental induction of HCC in rodents by DEN [25], 
due to the discovery of compounds with potential anti-cancer effect, 
is one of the best animal disease models for HCC [26] with similar 
imitation of this malignancy tumor in humans [27]. APG is a 
flavonoid with non-mutagenic activity that is found in natural food, 
such as a variety of fruits and vegetables [28]. Several studies were 
reported to possess anti-cancer activity through various mechanisms 
by APG; including induction of cell cycle arrest and apoptosis [29] 
inhibition of mutagenesis [30] and suppression of signal 
transduction [31]. 
 In our study, the considerable decrease in appetite and food 
intake in HCC group cause weight loss which could be an indirect 
suggestion of the decreasing hepatic function, and raise in the liver 
weight of the animals in HCC group, which could be assigned to 
the induction of tumors in the liver following DEN/2-AAF 
treatment [32]. Some studies have also confirmed these data and 
reported that the treated rats with this regime resulted in a marked 
decrease of final body weight and increase in liver weight [33]. 
 The results of this study also confirmed that damage to the liver 
is caused by DEN/2-AAF at/after week 15 of the HCC induction 
protocol. Raise of serum alpha-fetoprotein in the HCC rats might 
probably result from the toxic effects of DEN/AAF treatment, 
which induced genetic changes in the rodent liver cells [34], the 
reason why DEN/AAF treated animals could develop hepatocellular 
carcinoma [32].  
 The histopathological results in this study were supported by 
biochemical results obtained experimental animals. The hepatocytes 
showed variation in nuclear size and hyperchromatic nuclei. These 
results were all in agreement with the findings of previous 
investigates. This is attributed to metabolic activation of DEN in the 
rat liver and reactive metabolites generated which are recognized to 
damage hepatocytes [14, 32].  
 Mitochondria play important roles in cellular metabolism and 
death process. The alterations in genome, function, and structure of 
this organelle have been related to cancer. In many studies, due to 
these specific alterations, the mitochondria has been suggested as a 
promising target for cancer therapy [15b].  
 Several studies have shown that the mitochondria were 
differences in tumor tissue than in normal tissue, such as grow 
faster, fewer and smaller and also had the morphological 
transformed. It has also been observed that mitochondria from liver 
tumours are more fragile than those of normal liver [32]. 
 In this study, we assayed the effect of APG on hepatocyte 
viability (24 h) obtained from HCC rats at various concentrations 
(2.5–100 µM). APG significantly decreased the viability of HCC 
hepatocytes at all concentrations using MTT assay. This finding 
was quite in agreement with previous investigations regarding the 
capability of APG at decreasing cell viability in the various cancer 
cells [7]. Besides, APG at the concentrations 5-100 µM also 
significantly reduced the activity of SDH in the mitochondria 
obtained from cancerous but not cancerous hepatocytes, confirming 
selective and direct action of this flavonoid on tumor cell 
mitochondria [35]. 
 Natural compounds such as flavonoids can act, as a double-
edged sword under certain conditions, as pro-oxidants and so, 
increase the oxidation of other compounds. These important 
circumstances depend on the total number of OH groups in a 
flavonoid molecule and involvement of free transition metal ions in 
oxidation processes and concentration of flavonoids [36]. It has 
been previously shown that biological effects of flavonoids 
(Particularly anticancer effect) may be mediated via pro-oxidant 
action. In cancer, the regulatory mechanisms of cell growth and 
proliferation moderated via flavonoids is widely complex: at low 
level of ROS can stimulate the cell division and the promotion of 
tumor growth, and a high level of ROS is cytotoxic to the cell and 
can cause apoptosis. Cancer cells exhibit a higher and more 
persistent oxidative stress level compared to normal cells, rendering 
tumor cells more vulnerable to being killed by drugs (some 
flavonoids) that raise ROS levels [36]. 
 Our results both fluoremetric and flowcytometric techniques 
showed that APG raised ROS production only in the hepatocytes 
and mitochondrial isolated from the HCC group BUT NOT 
untreated control group. This is also in agreement of another 
published work indicated that ROS may act a key role in apoptosis 
signaling caused by APG in the ANA-1 cells [37]. 
 The results of previous studies showed that ROS play a pivotal 
role in any stage of the carcinogenesis process. The mechanism of 
cell growth and proliferation by flavonoids in cancer, is complex, 
so that ROS in low concentrations of may promote the cell mitosis 
leading to tumor growth, On the other hand, at high levels, ROS is 
cytotoxic and the could stimulate apoptosis signaling [38].  
 Carcinogenesis is a multistage process [39]. Indeed, oxidative 
damage has been suggested to implement a key role in the 
promotion of tumorgenesis, in spite of the counteracting effect of 
the cellular antioxidant defense system. In fact, newly many in vitro 
researches on flavonoids with anti-cancer activity through the 
induction of oxidative stress have been performed [40]. 
Fortunately, our results confirmed selectivity and potentiality of 
APG on HCC tumor cell mitochondria. 
 Our results obtained by both fluoremetric and flowcytometric 
techniques showed that APG induced significant decrease in the 
level of ΔΨm in mitochondria isolated from hepatocytes of the only 
HCC rat group but not in those of the untreated control rat group. It 
is well known that mitochondria can play a role in the execution of 
apoptosis and also in death signal transduction through the MPT 
pore opening which is consequent to membrane potential collapse 
and cytochrome c expulsion into the cytoplasm through activation 
of caspase-3 following apoptosome formation [41]. Another study 
showed that treatment of A549 cells with APG leads to a decline in 
the level of ΔΨm, expulsion of cyt c and other pro-apoptotic agents 
from mitochondria before the induction of apoptosis [7, 42]. 
 The mitochondrial swelling and cyt c expulsion as subsequent 
events following mitochondrial permeability transition were also 
monitored in this study. As mentioned earlier, APG (10, 20 and 40 
µM) induced selective effects on mitochondria obtained from 
hepatocytes of only HCC rats. The inhibition of cyt c release by the 
pre-exposure of CsA and BHT in the HCC mitochondria supports 
the hypothesis that apoptosis signaling induction by APG is a result 
of oxidative stress process and opening of the MPT pores.  
 Apoptosis is a process that majorly regulates cell number and 
proliferation as part of the normal development process. However, 
cancer cells tend to inactivate the cell cycle control points and the 
eventual progression of apoptosis. Therefore, the stimulation of 
apoptosis has been emphasized in a study on anticancer strategies 
[43]. Previous reports indicate that different flavonoids could 
activate the proteolytic activity of caspases, support their value as 
potential anticancer candidates for regulating tumor growth [43].  
 To test the aforementioned effects of APG, there is a need to 
check whether APG is able to induce apoptosis in HCC cells. 
Apoptosis or Type I cell death, which occurs either through 
intrinsic or extrinsic pathways, requires the activation of the 
caspases cascade. In this study, the mode of APG- induced 
apoptosis signaling was examined by the assessment of caspase-3 
activity. The incubation of hepatocytes from HCC rats in a medium 
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containing APG (10µM), resulted in a statistically significant 
increase in caspase-3 activity in comparison with control 
hepatocyte. In line with the results of this study, it has already been 
reported that APG can act as a therapeutic agent by orchestrating a 
caspase-3 dependent apoptotic pathway [44]. Phosphatidylserine 
externalization is one of the earliest phenomena in apoptosis, which 
can be determined by annexin V and PI staining. The incubation of 
liver hepatocytes obtained from only HCC rats with APG for 6, 12 
and 24 h resulted in significant raise in percentage of apoptosis 
phenotype. In general, the outcome of this study's cellular and 
mitochondrial experiments suggests that APG –selectively induced 
apoptosis in HCC rat hepatocytes by directly acting on their 
mitochondria. 
 Finally, the results of our study indicated that APG increases 
the mitochondrial ROS formation through the disruption of MMP 
only in the mitochondrial isolated from the liver of HCC rats. This 
process resulted in a decrease in the MMP, alteration of 
mitochondrial swelling and release of cyt c, which can selectively 
orchestrate apoptosis signaling in liver hepatocytes of cancerous 
HCC rats.  
 The anticancer vision is based on cytotoxic molecules that 
selectively target mitochondria and induce perturbation of the 
organelle in only cancerous cells, thereby bypassing upstream pro-
apoptotic events that probably are defects in the tumor cell [45]. 
Most of these anticancer candidate molecules (especially 
flavonoids, such as myricetin [46], luteolin [47] and kaempeferol 
[48]) target the mitochondrial permeability transition (MPT) pores 
either by directly binding to a specific pore molecule or through 
enhancing of ROS formation resulting from mitochondrial 
respiratory chain disruption or Ca+2 influx. These events lead to 
mitochondrial membrane permeability transition, mitochondrial 
swelling, and finally cytochrome c expulsion from the mitochondria 
and formation of the apoptosome in the cytosol of tumor cell 
caspase-3 activation [45, 49].  
 In our current research, it is likely that apigenin can increase 
ROS generation through disruption in ETC. The increased ROS 
could oxidize the thiol groups surrounding the MPT pore and 
change the status of pore into open. These thiol groups originated 
from mitochondrial GSH, bound to their receptors located around 
MPT pores. Oxidation of surrounding reduced thiol groups resulted 
in disulphide bridge formation which induce mechanical pressure 
on mitochondrial membrane leading to opening of pores. Therefore, 
collapse of MMP, an event which is subsequent by influx of 
osmolites into mitochondrial inter-membrane and cause 
mitochondrial swelling.  
 Other results also showed that apigenin induced MMP decline 
and cytochrome c expulsion was prevented by BHT, which is an 
antioxidant suggesting that MPT pore opening was a subsequent of 
ROS formation. This effluxes cytochrome c and other apoptogenic 
proteins from the mitochondria and ignite the apoptosis signaling 
through the formation of apoptosome complex and caspase-3 
activation, in HCC hepatocytes.  
CONCLUSION  
 In this study, it was shown that APG is an effective anti-HCC 
candidate with very low and ignorable cytotoxicity towards normal 
liver cells. This research adds evidence that APG could selectively 
induce apoptosis in HCC hepatocytes and inhibit tumor growth by 
directly targeting mitochondria. According to our findings, APG 
can be recommended as a new anti HCC drug candidate.  
LIST OF ABBREVIATIONS 
2-AAF = 2-acetylaminofluorene 
AFP = Alpha-fetoprotein 
APG = Apigenin 
DEN = Diethylnitrosamine 
HCC = Hepatocellular carcinoma 
MMP = Mitochondrial Membrane Potential 
ROS = Reactive Oxygen Species 
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